Institutional Manager · CIK 0001909617
Qiming U.S. Ventures Management, LLC
Bellevue, WA · File #028-22101
Latest AUM
$55.6M
Positions
4
Top-10 Concentration
100.0%
Filings
11
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Sep 20254 pos · $55.6M
- 13F HOLDINGS REPORTQ/E Jun 20256 pos · $23.6M
- 13F HOLDINGS REPORTQ/E Mar 20256 pos · $23.1M
- 13F HOLDINGS REPORTQ/E Dec 20246 pos · $51.1M
- 13F HOLDINGS REPORTQ/E Sep 20246 pos · $51.4M
- 13F HOLDINGS REPORTQ/E Jun 20246 pos · $52.6M
- 13F HOLDINGS REPORTQ/E Mar 20246 pos · $89.7M
- 13F HOLDINGS REPORTQ/E Dec 20237 pos · $75.3M
- 13F HOLDINGS REPORTQ/E Sep 20237 pos · $95.2M
- 13F HOLDINGS REPORTQ/E Jun 20237 pos · $82.6M
- 13F HOLDINGS REPORTQ/E Mar 20237 pos · $75.6M
Top 4 Holdings — Sep 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | TOURMALINE BIO INC | 89157D105 | 741,691 | $35.5M | 63.76% |
| 2 | KORRO BIO INC | KRRO | 368,085 | $17.6M | 31.68% |
| 3 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $2.2M | 3.97% |
| 4 | KEZAR LIFE SCIENCES INC | KZR | 82,871 | $323,197 | 0.58% |